Effect of synthetic truncated apolipoprotein C-I peptide on plasma lipoprotein cholesterol in nonhuman primates

Rampratap S. Kushwaha, Henry C. McGill, Frederick H. Hausheer

Research output: Contribution to journalArticlepeer-review

Abstract

The present studies were conducted to determine whether a synthetic truncated apoC-I peptide that inhibits CETP activity in baboons would raise plasma HDL cholesterol levels in nonhuman primates with low HDL levels. We used 2 cynomolgus monkeys and 3 baboons fed a cholesterol- and fat-enriched diet. In cynomolgus monkeys, we injected synthetic truncated apoC-I inhibitor peptide at a dose of 20 mg/kg and, in baboons, at doses of 10, 15, and 20 mg/kg at weekly intervals. Blood samples were collected 3 times a week and VLDL + LDL and HDL cholesterol concentrations were measured. In cynomolgus monkeys, administration of the inhibitor peptide caused a rapid decrease in VLDL + LDL cholesterol concentrations (30%-60%) and an increase in HDL cholesterol concentrations (10%-20%). VLDL + LDL cholesterol concentrations returned to baseline levels in approximately 15 days. In baboons, administration of the synthetic inhibitor peptide caused a decrease in VLDL + LDL cholesterol (20%-60%) and an increase in HDL cholesterol (10%-20%). VLDL + LDL cholesterol returned to baseline levels by day 21, whereas HDL cholesterol concentrations remained elevated for up to 26 days. ApoA-I concentrations increased, whereas apoE and triglyceride concentrations decreased. Subcutaneous and intravenous administrations of the inhibitor peptide had similar effects on LDL and HDL cholesterol concentrations. There was no change in body weight, food consumption, or plasma IgG levels of any baboon during the study. These studies suggest that the truncated apoC-I peptide can be used to raise HDL in humans.

Original languageEnglish (US)
Pages (from-to)177-184
Number of pages8
JournalJournal of Biomedicine and Biotechnology
Volume2004
Issue number4
DOIs
StatePublished - Sep 30 2004
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Genetics
  • Applied Microbiology and Biotechnology

Fingerprint Dive into the research topics of 'Effect of synthetic truncated apolipoprotein C-I peptide on plasma lipoprotein cholesterol in nonhuman primates'. Together they form a unique fingerprint.

Cite this